Summary RTI Surgical, Inc. (RTI), formerly RTI Biologics, Inc., is a surgical implant company that develops and markets biologic, metal and synthetic implants. The company's products include spine implants, sports medicine implants, surgical specialties, cardiothoracic and orthobiologics. It offers spine implants such as anterior cervical plate system, demineralized bone matrix powder, cequence anterior cervical plate system, cancellous chips and spinal cable system and others. RTI also offers dbm putties, cellular allogeneic bone graft, bicortical allograft bone wedges, whole radius and cortical cancellous spacer among others. The company has manufacturing facilities throughout the US and Europe. RTI is headquartered in Alachua, Florida, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company RTI Surgical, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 RTI Surgical, Inc. Company Snapshot 5 RTI Surgical, Inc. Company Overview 5 RTI Surgical, Inc. Pipeline Products and Clinical Trials Overview 6 RTI Surgical, Inc. - Pipeline Analysis Overview 8 Key Facts 8 RTI Surgical, Inc. - Major Products and Services 9 RTI Surgical, Inc. Pipeline Products by Development Stage 10 RTI Surgical, Inc. Pipeline Products Overview 11 CR-Plug 11 CR-Plug Product Overview 11 Traditional Allograft 12 Traditional Allograft Product Overview 12 Xenograft Tendon 13 Xenograft Tendon Product Overview 13 RTI Surgical, Inc. - Key Competitors 14 RTI Surgical, Inc. - Key Employees 15 RTI Surgical, Inc. - Locations And Subsidiaries 16 Head Office 16 Other Locations & Subsidiaries 16 Recent Developments 17 RTI Surgical, Inc., Recent Developments 17 Apr 28, 2016: RTI Surgical Announces 2016 First Quarter Results 17 Apr 20, 2016: RTI Surgical Announces Launch of Release Laminoplasty Fixation System 17 Apr 11, 2016: RTI Surgical Announces Launch of Streamline TL Spinal Fixation System - Deformity Instrumentation 18 Feb 26, 2016: Curt Selquist Elected Chairman, Peter Gearen Elected as Vice Chairman of RTI Surgical's Board 18 Feb 23, 2016: RTI Surgical Announces Limited Launch and First Implantation of Unison-C Anterior Cervical Fixation System 19 Feb 16, 2016: RTI Surgical Announces 2015 Fourth Quarter, Full Year Results, 2016 Financial Guidance 19 Jan 08, 2016: RTI Surgical Announces Preliminary 2015 Fourth Quarter, Full Year Revenue 21 Oct 29, 2015: RTI Surgical Announces 2015 Third Quarter Results 21 Oct 26, 2015: Christopher R. Sweeney, Thomas A. McEachin Join RTI Surgical Board Of Directors 22 Jul 30, 2015: RTI Surgical Announces 2015 Second Quarter Results 23 Appendix 24 Methodology 24 About GlobalData 24 Contact Us 24 Disclaimer 24
List of Tables
RTI Surgical, Inc. Pipeline Products and Clinical Trials Overview 6 RTI Surgical, Inc. Pipeline Products by Equipment Type 6 RTI Surgical, Inc. Pipeline Products by Indication 7 RTI Surgical, Inc., Key Facts 8 RTI Surgical, Inc., Major Products and Services 9 RTI Surgical, Inc. Number of Pipeline Products by Development Stage 10 RTI Surgical, Inc. Pipeline Products Summary by Development Stage 10 CR-Plug - Product Status 11 CR-Plug - Product Description 11 Traditional Allograft - Product Status 12 Traditional Allograft - Product Description 12 Xenograft Tendon - Product Status 13 Xenograft Tendon - Product Description 13 RTI Surgical, Inc., Key Employees 15 RTI Surgical, Inc., Subsidiaries 16
List of Figures
RTI Surgical, Inc. Pipeline Products by Equipment Type 7 RTI Surgical, Inc. Pipeline Products by Development Stage 10
Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous industRead More...
Global microcontroller market is estimated to be valued at USD 26.9 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing demand in key application areas such as automotive, consumer electronics and healthcare is expected toRead More...
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...
Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expeRead More...
Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving creamRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.